SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Spectranetics (SPNC): Any info?
SPNC 38.450.0%Aug 10 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: steve berman who wrote ()8/6/1998 11:53:00 AM
From: Don C.   of 60
 
Spectranetics Gets Conditional FDA OK To Test Laser Tech

COLORADO SPRINGS, Colo. (Dow Jones)--Spectranetics Corp. (SPNC) received conditional approval from the Food and Drug Administration to begin a trial of its excimer laser angioplasty catheter, designed to treat blockages in leg arteries.

In a press release Thursday, Spectranetics said that if the randomized trial, at 10 medical instituions, is successful, it plans to apply for a pre-market approval application.

The treatment uses fiber optic technology to dissolve blockages.

Spectranetics develops technology for interventional cardiovascular therapy.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext